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ABSTRACT
Cervical cancer is the most frequently diagnosed malignant disease in pregnancy. The clinical symptoms
are scarce or none. The diagnosis is made primarily with a cervical smear, as well as a colposcopic
examination and directed cervical biopsy. The treatment of cervical cancer depends on the stage of the
disease, the gestation period, and a patient’s wish to carry a pregnancy to term. The illustrated case is
of a patient who with the diagnosed presence of microinvasive squamous cell cancer, due to cervical
biopsy, in the 1st trimester of pregnancy. In the 2nd trimester, diagnostic conization was performed in
order to exclude the presence of the invasive disease. The definite histopathologic findings indicated the
presence of cancer in situ. The conization margins were negative and thus the patient was successfully
cured. The patient had a cesarean birth in the 36th week of pregnancy and she gave birth to an alive
female newborn. Women are given the chance to have cervical cancer diagnosed and treated in the early
stages of pregnancy owing to the introduction of a cervical smear in the modern protocol of antenatal
protection.
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INTRODUCTION 
C
ervical cancer, one of the most common cancer in women’s reproduction period, is the
most frequently diagnosed malignance during pregnancy (1, 2). The median age of cer-
vical cancer diagnosed in pregnancy has been reported to be 30 to 35 years of age. Reports
from tumor registries and large maternity hospitals throughout the world show an overall
incidence of cervical cancer in pregnancy ranging from 7.5 to 45.0 cervical cancers per
100,000 pregnancies (1,3,4).
Should only women in their fertility period be taken into consideration, the combination of
cervical cancer and pregnancy is found in up to 10% of the cases (5,6).
There is a strong causal relationship between the HPV (human papillomavirus) infection and
the presence of the displastic lesions of the cervix and cervical cancer. HPV is nowadays
considered the primary cause of the beginning of cervical cancer. The existence of the DNA
sequence of HPV virus is proved in more than 93% of all cervical cancers (7). Except for
the HPV infection, there are many other contributive factors: smoking, the use of oral con-
traceptives (in connection with sexual behavior), young age at first sexual intercourse, hav-
ing numerous sexual partners, a high number of childbirths, the first childbirth at an early
age, the consumption of certain vitamins such as carotenoid, vitamin C and folic acid, the
presence of other sexually transmitted diseases, and the decrease in humoral and cellular
immunity (8-10).
The symptoms of the presence of cervical cancer in pregnancy are the same as with
women who are not pregnant. Vaginal bleeding is the most common (43%-54%), while
30% to 50% of pregnant women experience no symptoms whatsoever (11). Diagnosis is
based on an examination of the cervix and on taking a cytological cervical smear, colpo-
scopic findings; and if necessary a targeted cervical biopsy. The stage of the disease dur-
ing pregnancy is also defined according to FIGO classification. The most frequent histolog-
ical type of cervical cancer in pregnancy, as well as in not pregnant women, is squamous
cell carcinoma (80%); less frequently is cervical adenocarcinoma (about 11%) (1).
Cervical cancer is curable if it is diagnosed and treated on time i.e., in its early stages. There
is a significant dilemma about the treatment of cervical cancer in pregnant women. The
treatment depends on the stage of the disease, but also on the patient’s age i.e. on the abil-
ity of the fetus to survive outside the uterus at that moment. The wish of a patient to carry
pregnancy to term can also significantly postpone the treatment and consequently its out-
come and result. Optimum outcome of the treatment would mean: a) preserving the life of
a pregnant women, b) optimum cure of the malignant disease, c) protecting the fetus as
well as the newborn baby from potentially harmful effects of the treatment, d) preserving a
woman’s procreation ability (12).
CASE REPORT
In July 2004, a 27 years old woman came for a gynecological examination in the 14th week
of pregnancy. The case history then taken was that she had been feeling well, and that dur-
ing her previous pregnancy, in January 2002, she had been diagnosed as having cervical
ectopy and the presence of koilocytes in the class II cervical smear. At that time, HPV typ-
ing had not been done. Six weeks later, a repeated cervical smear was again class II, so the
patient was suggested that she should have a check-up six weeks after the childbirth. She
gave a vaginal birth to a male newborn whose birth weight was 3350 g. However, the146
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patient did not go for a suggested check-up.
In the 10th week of the pregnancy in question, she began bleeding and thus went to a gyne-
cologist. The examination showed the presence of ectopy with atypical vascularization. A
cervical smear taken was class III. Upon biopsy, she was diagnosed as having microinva-
sive squamous cell carcinoma.
With this diagnosis, she was sent to the Institute of Oncology in Sremska Kamenica. After
hospitalization, a gynecological examination was done and following findings were
obtained: the outer genitals - without changes; the vagina - penetrable with two fingers, soft,
elastic walls, livid; the cervix - cylindrical, the orificium closed, papillary ectopy around the
orificium 3 x 3 cm; the uterus - normal uterus size for the time of pregnancy, soft, without
contractions; the adnexa bilateral - without changes. The preoperative ultrasound findings
were: the normal quantity of amniotic fluid, the placenta at the posterior wall of the uterus,
BPD: 47.5 mm, THQ: 41.6 mm, FL: 28.7 mm, the fetus’s heart beat and movement were
registered. Based on the decision of the oncology commission, conization of cervix was
performed and a cervical cerclage in the 18/19th week of pregnancy. There were no oper-
ative and immediate postoperative complications. The postoperative ultrasound findings
were: normal structure of the placenta at the posterior wall, the normal quantity of amniot-
ic fluid, the fetus’s spine and limbs of normal findings, the umbilical cord with three blood
vessels inside of it, BPD: 45.7 mm, FL: 27.9 mm, the fetus’s heart beat and movement were
registered. The patient was given a tocolytic therapy perorally (Ritodrine tablets) and was
discharged on the day 7 after the operation. The patient’s general state of health was satis-
factory. She had to continue with the therapy and was advised to go on regular check-ups. 
The pathologist has analyzed 37 H&E stained slides from cervical excision materials (from
a cone biopsy of the cervix). Based on morphologic criteria, carcinoma in situ was detect-
ed in 9 cervical tissue samples. There was no evidence of penetration of basement mem-
brane. Endocervical and exocervical margins were not involved (Figure 1, 2).
The pregnancy continued without any problems until the week 33/34, when the patient was
brought to the Obstetrics and Gynecology Clinic, in Novi Sad, due to profound bleeding. She
was examined upon the hospitalization and the findings obtained were: a small amount of
spotting in the vagina, the presence of a cervical cerclage after conization. There were vis-
ible contractions of the uterus during the examination. The patient was given an intravenous
tocolytic therapy (Fenoterol ampule, No II in 500 ml of 5% glucose IV) and a corticosteroid
therapy (Dexamethasone 4 x 6 mg IM). The complete lab test was done. On the second day
of the hospitalization, she was also administered ceftriaxone 2 x 1 g IM due to fever (the
patient’s temperature was 38…C). Her urine, cervical smear, vaginal fluids, and throat and
nose smear were taken for the bacteriological examination. On the day 4 of the antibiotic
therapy, the patient developed the allergic reaction to Ceftriaxone. The findings of bacterio-
logical examination of urine were positive (isolated Enterococcus species) and thus gen-
tamicin a 120mg, 2x1 amp IM was added to the therapy. The other lab results were normal,
and the results of all the smears negative. A cervical smear result was class II.
The findings of the ultrasound examination of the fetus were: BPD 8 mm, FL 63 mm, HC
300 mm, AC 319 mm, the placenta at the anterior wall of the uterus, placental maturity
stage II, the normal quantity of amniotic fluid. The estimated weight of the fetus was 2500
g. The fetus’s left kidney was polycystic.
Despite the tocolytic therapy (which was administered perorally but also intavenously when
the contractions were stronger), the patient continued having contractions; and thus had a
cesarean birth in the 36th week of pregnancy. She gave birth to an alive female newborn
whose birth weight was 3060 g. After the birth, Apgar score was 7/9. On day 2 of the post-
operative recovery, the patient’s temperature raised  up to 38…C, so the antibiotic therapy
was continued. She was discharged on the 5th postoperative day. Her general state of
health was satisfactory. Due to its prematurity, the baby was sent to the Institute for Health
Protection of Children and the Young in Novi Sad. 
Four months later, the patient came on a regular gynecological check-up. A cervical smear
was taken with class II result.
DISCUSSION AND CONCLUSION
Early pregnancy gives a unique opportunity for diagnosing premalignant and malignant dis-
ease of cervix. A woman’s suspicion that she may be pregnant is a reason for going to a
gynecologist. One part of a routine examination in early pregnancy is a specula examination
for cervix visualization and taking a cervical smear, from both ecto- and endocervix, for the
cytological examination, apart from a bimanual palpatory examination and an ultrasound for
fetus viability. Taking ecto- and endocervical smear for cytological examination is the most
important in a diagnosis. A patient with abnormal test results of a cervical smear has to
undergo a colposcopic examination. In most cases, this examination during pregnancy
enables the visualization of the complete area of transformation because of the eversion of
the squamocolumnar junction, which is a normal physiological process happening in the
first trimester of pregnancy. Colposcopy is rather difficult in pregnancy, even for an experi-
enced gynecologist, because of the physiological changes of the cervix resulting from the
activity of the hormones. It is necessary to have a good knowledge of physiological
Figure 1. Cervical in situ squamous cell carcinoma. (H&E, magnification 5x10)
Figure 2. In situ cervical squamous cell carcinoma. (H&E, magnification 10x10). Endocervical glands
entirely replaced by atypical squamous cells, circumscribed with intact basal membrane
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processes in order not to diagnose as suspicious something that it is not (13,14).
When colposcopic findings are abnormal or when there is a suspicion of invasive cancer,
it is necessary to perform a targeted biopsy. Colposcopy and a targeted biopsy during preg-
nancy are exact and accurate methods of the examination of a pregnant woman who has
abnormal cervical cytology findings. There is a good correlation between colposcopic and
histopathological findings in pregnancy (14).
Conization as a diagnostic - therapeutic method is performed during pregnancy only in
extremely selective cases because of possible complications that can jeopardize both a
mother and her fetus. As a result, the performance of conization is necessary only in the
case of unsatisfactory coloscopic findings and there is a suspicion of an invasive cancer.
Equally so, if the results of the biopsy indicate the presence of microinvasion it is neces-
sary to perform conization in order to exclude the presence of invasive cancer. Conization
during pregnancy is performed only as a diagnostic method owing to a high percentage of
positive conization margins and a residual disease. The described incidence of a residual
disease after conization during pregnancy is up to 50% (14).
Complications resulting from conization in pregnancy can be various. Postoperative bleed-
ing occurs in about 55 to 14% cases, bearing in mind that the risk increases with the
progress of pregnancy. Miscarriage occurs in 3 - 6%, however, if conization is performed
in the 1st trimester, the risk is higher i.e. 33 - 50% (15). Owing to above mentioned, it is
recommended to postpone conization to the 2nd trimester even if the illness was detected
in the 1st trimester of pregnancy. In that case cervical stenosis, PROM, intrauterine infec-
tion or a premature birth occur more seldom (16).
The biopsy of the patient above mentioned indicated the presence of microinvasive cancer.
Conization was performed to eliminate existence of invasive cancer and than performed the
cerclage. The definite histopathological findings showed the presence of cancer in situ and
that the change had been removed leaving the satisfactory thickness of the healthy tissue
around the cancer. The majority of authors agree that the definite treatment of in situ and
microinvasive cancer based on the histopathological verification (biopsy and conization)
can be delayed to after childbirth.
It appears that pregnancy-associated cervical carcinoma has an overall better prognosis
than in the non-pregnant population due to the relatively high proportion of patients with
early stage disease. After stratifying for stage, survival analyses generally do not show a dif-
ference between the two groups (17). Due to diagnostic and therapeutic difficulties associ-
ated with it in pregnancy, re-evaluation after delivery is crucial. Our patient had a cesarean
birth, although the latest data in medical literature suggests a possibility of vaginal birth in
cases of cervical in situ cancer (3,12,18).
However, the risks of obstructed labor, hemorrhage and episiotomy site recurrence with
vaginal delivery has led to the recommendation of caesarean delivery as the preferred
method (19).
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